Chris Garabedian founded Xontogeny in 2016 and joined Perceptive Advisors in 2017, where he manages the Perceptive Xontogeny Ventures Fund. He previously led Sarepta Therapeutics and held roles at Celgene and Gilead.
What Chris can write
Career
- Gilead · global commercial and corporate development leadership roles1997-2005
- Celgene · led Corporate Strategy2007-2010
- Sarepta Therapeutics · President and CEO2011-2015
- XontogenyNow
- Perceptive Advisors · Portfolio Manager2017
Companies founded
Focus
Also at Xontogeny
Partners like Chris
At firms with a similar stage, sector and check size.
Alert me when Xontogeny is active
One email when Chris's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Chris Garabedian?
Chris Garabedian founded Xontogeny in 2016 and joined Perceptive Advisors in 2017, where he manages the Perceptive Xontogeny Ventures Fund. He previously led Sarepta Therapeutics and held roles at Celgene and Gilead.
How much does Chris Garabedian invest?
Xontogeny has not reported a check size. It invests at seed.
How do I pitch Chris Garabedian?
Email [email protected], the firm's inbox for founders, and name Chris in the subject. A warm intro from a founder Xontogeny backed works better.
What did Chris Garabedian do before Xontogeny?
global commercial and corporate development leadership roles at Gilead; led Corporate Strategy at Celgene; President and CEO at Sarepta Therapeutics; Portfolio Manager at Perceptive Advisors.
Last updated 2026-10-15. Is this you? Ask for a correction.